In conclusion, our integrative multi-omics approach uncovered metabolic–immune heterogeneity in sepsis, established a robust immune–metabolic risk score system, and identified GYG1 as a potential metabolic driver of innate immune hyperactivation. This evidence concerns the gene GYG1 and Sepsis.